CH668185A5 - Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten. - Google Patents

Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten. Download PDF

Info

Publication number
CH668185A5
CH668185A5 CH4235/86A CH423586A CH668185A5 CH 668185 A5 CH668185 A5 CH 668185A5 CH 4235/86 A CH4235/86 A CH 4235/86A CH 423586 A CH423586 A CH 423586A CH 668185 A5 CH668185 A5 CH 668185A5
Authority
CH
Switzerland
Prior art keywords
active ingredient
isopropylamino
pyrrolyl
propanol
phenoxy
Prior art date
Application number
CH4235/86A
Other languages
German (de)
English (en)
Inventor
Joachim Dr Jaekel
Nicole Veillon
Franz Dr Ostermayer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CH4235/86A priority Critical patent/CH668185A5/de
Priority to IL84207A priority patent/IL84207A0/xx
Priority to EP87810604A priority patent/EP0265388A1/de
Priority to DE19873735641 priority patent/DE3735641A1/de
Priority to SE8704093A priority patent/SE8704093L/xx
Priority to GB08724670A priority patent/GB2197315A/en
Priority to FI874643A priority patent/FI874643A/fi
Priority to PT85976A priority patent/PT85976B/pt
Priority to GB878724760A priority patent/GB8724760D0/en
Priority to DD87308190A priority patent/DD266351A5/de
Priority to GR871634A priority patent/GR871634B/el
Priority to FR8714607A priority patent/FR2605629A1/fr
Priority to AT0281087A priority patent/ATA281087A/de
Priority to IE872860A priority patent/IE872860L/xx
Priority to JP62266660A priority patent/JPS63115858A/ja
Priority to NO874425A priority patent/NO874425L/no
Priority to HU874756A priority patent/HUT45492A/hu
Priority to AU80077/87A priority patent/AU8007787A/en
Priority to NL8702533A priority patent/NL8702533A/nl
Priority to KR870011762A priority patent/KR880005094A/ko
Priority to BE8701205A priority patent/BE1002060A3/fr
Priority to ZA877973A priority patent/ZA877973B/xx
Priority to DK554887A priority patent/DK554887A/da
Publication of CH668185A5 publication Critical patent/CH668185A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CH4235/86A 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten. CH668185A5 (de)

Priority Applications (23)

Application Number Priority Date Filing Date Title
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.
IL84207A IL84207A0 (en) 1986-10-24 1987-10-19 Pharmaceutical compositions containing a phenoxypropanolamine,a new form thereof and its preparation
EP87810604A EP0265388A1 (de) 1986-10-24 1987-10-19 Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung
DE19873735641 DE3735641A1 (de) 1986-10-24 1987-10-21 (+)-1-isopropylamino-3-(o-(pyrrol-1-yl) -phenoxy)-propanol, verfahren zu seiner herstellung sowie pharmazeutische praeparate und deren verwendung
SE8704093A SE8704093L (sv) 1986-10-24 1987-10-21 Terapeutiska medel och anvendning derav
GB08724670A GB2197315A (en) 1986-10-24 1987-10-21 Anti-anxiety propanolamine derivatives
FI874643A FI874643A (fi) 1986-10-24 1987-10-21 Terapeutiska medel och deras anvaendning.
PT85976A PT85976B (de) 1986-10-24 1987-10-22 Verfahren zur herstellung von (<)-1-isopropylamino-3-]o-(pyrrol-1-yl)-phenoxy"-2-propanol
GB878724760A GB8724760D0 (en) 1986-10-24 1987-10-22 Therapeutic compositions liquid crystal material
DD87308190A DD266351A5 (de) 1986-10-24 1987-10-22 Verfahren zur herstellung von (+)-1-isopropylamino-3-[o-(pyrrol-1-yl)-phonoxy]-2-propanol
GR871634A GR871634B (en) 1986-10-24 1987-10-22 Therapeutic mean and its usage
FR8714607A FR2605629A1 (fr) 1986-10-24 1987-10-22 Agent therapeutique et son utilisation
AT0281087A ATA281087A (de) 1986-10-24 1987-10-23 Neue therapeutische pyrrolderivate und ihre verwendung
IE872860A IE872860L (en) 1986-10-24 1987-10-23 Therapeutic compositions and use thereof
JP62266660A JPS63115858A (ja) 1986-10-24 1987-10-23 医薬組成物
NO874425A NO874425L (no) 1986-10-24 1987-10-23 Fremgangsmaate til fremstilling av (+)-1-isopropylamino-3-(o-pyrrol-l-yl)-fenoksy)-2-propanol og dets salter.
HU874756A HUT45492A (en) 1986-10-24 1987-10-23 Process for producing /+/-1-isopropylamino-3-square brackets open 0-/pyrrol-1-yl/-phenoxy square brackets closed-2-propanol and its salts and pharmaceutics comprising these compounds as active ingredient
AU80077/87A AU8007787A (en) 1986-10-24 1987-10-23 (+)-1-isopropylamino-3-{0-(pyrrol-1-yl)phenoxy}-2-propanol
NL8702533A NL8702533A (nl) 1986-10-24 1987-10-23 (+)-1-isopropylamino-3-0-(pyrrool-1-yl)-fenoxy-2-propanol of een zout daarvan, een werkwijze ter bereiding van het propanolderivaat en zouten ervan alsmede farmaceutische preparaten, die deze verbindingen bevatten.
KR870011762A KR880005094A (ko) 1986-10-24 1987-10-23 치료제 조성물 및 이의 용도
BE8701205A BE1002060A3 (fr) 1986-10-24 1987-10-23 Agent therapeutique et son utilisation.
ZA877973A ZA877973B (en) 1986-10-24 1987-10-23 Therapeutic compositions and use thereof
DK554887A DK554887A (da) 1986-10-24 1987-10-23 Terapeutisk middel samt dets anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.

Publications (1)

Publication Number Publication Date
CH668185A5 true CH668185A5 (de) 1988-12-15

Family

ID=4272328

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.

Country Status (4)

Country Link
JP (1) JPS63115858A (ja)
CH (1) CH668185A5 (ja)
DD (1) DD266351A5 (ja)
ZA (1) ZA877973B (ja)

Also Published As

Publication number Publication date
ZA877973B (en) 1988-04-25
DD266351A5 (de) 1989-03-29
JPS63115858A (ja) 1988-05-20

Similar Documents

Publication Publication Date Title
DE602004010531T2 (de) Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
DE2522655A1 (de) Benzo(b)thiophenverbindungen verfahren zu deren herstellung sowie diese enthaltende pharmazeutischen zusammensetzungen
EP0472501B1 (de) Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate
CH644518A5 (de) Pharmazeutisches praeparat zur regulierung des knochenmetabolismus.
DE2713103A1 (de) 1-nitro-9-dialkylaminisoalkylaminakridine oder ihre salze und verfahren zu ihrer herstellung
DE10360869A1 (de) Verwendung von Fumarsäurederivaten zur Therapie der Herzinsuffizienz, der Hyperkeratose und von Asthma
DE2625012C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
EP0011818B1 (de) Arzneimittel bzw. pharmazeutische Zusammensetzungen auf der Basis von Aldosteronantogonisten und Diuretica sowie Verfahren zu ihrer Herstellung
DE2157272C3 (de) Verwendung von bis-(p-Chlorphenoxy)acetylharnstoff
DE2463088C1 (de) Substituierte Thienylverbindungen,Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2123318C2 (de) 4-Butylamino-1-äthyl-1H-pyrazolo[3,4-b]pyridin-5-carbonsäureäthylester, Verfahren zu dessen Herstellung und diesen enthaltende pharmazeutische Mittel
DE2621082C2 (de) Piperazinderivat, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH668185A5 (de) Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.
DE2609746A1 (de) Piperazinverbindungen sowie arzneimittel, die diese verbindungen enthalten
DE2451933C2 (ja)
EP0508955A1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
EP0524512B1 (de) Antihypertensive Kombination
DE60109799T2 (de) Verwendung von quetiapin für aufmerksamkeitsmangel-hyperaktivitätsstörungen oder verhaltensstörungen
DE3500756A1 (de) Verwendung von chinolonen zur behandlung der herzinsuffizienz
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE1445416C3 (de) N-substituierte 23-Polymethylenindole, ein Verfahren zu ihrer Herstellung und Arzneimittel
DE1518444C (de) erythro alpha Phenyl beta amino propanole, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arz neimittel
AT321274B (de) Verfahren zur Herstellung von neuen 1-(3&#39;-Hydroxyphenyl)-2-äthylamino- oder -2-isopropylaminopropanen und deren Säureadditionssalzen
DE3242922A1 (de) Phenylpropanolamine, ihre herstellung und verwendung
DE2704744C2 (de) Fettsäureamide von &amp;alpha;-Methyl-m-(trifluormethyl)-phenäthylamin, Verfahren zu ihrer Herstellung und Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased